Rob Hall is a Consultant at Multiple Clients. He possess expertise in venture capital, due diligence, financial analysis, business strategy, start ups and 15 more skills. Colleagues describe him as "Rob provided a critical role in Cytochroma's series B financing, serving as the (representative of the) lead investor. Rob led the due diligence and negotiated the term sheet which was used to leverage a total of $22 million from a syndicate including a total of 9 venture capital groups. This was one of the largest syndicated venture capital financings of a Canadian biotechnology company and Rob was the catalyst to make it happen. Subsequently Rob represented BDC on the board of… Show more"